Key result
Stepwise management of coexisting hypertension and diabetes is essential to curb mounting cardiovascular risk.
Why the study?
Hypertension and diabetes frequently coexist and their increasing prevalence significantly raises global cardiovascular risk with important clinical and social implications.
Supports individualized multifactorial management in comorbid hypertension and diabetes; extends evidence on compounded cardiovascular risk but requires prospective validation.
Hypertension and diabetes are two cardiovascular diseases which frequently coexistence, are high prevalence is likely to continue increasing considerably, influences on increasing of global cardiovascular risk and results with important clinical and social determinants. Treatment goals can be individualized in a stepwise approach, including lifestyle modification, psychosocial factors, risk factor treatment, and social determinants, targets and goals for LDL-C, BP, and glycaemic control.
No takes yet. Share an insight, caveat, or question.
Popescu et al. (2022) conducted a review in Hypertension and diabetes. Stepwise individualized management (lifestyle and risk factor treatment) was evaluated. Individualized, stepwise management of coexisting hypertension and diabetes, including lifestyle modifications and risk factor targets, is required to address increasing global cardiovascular risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: